Nitya Nair

2.1k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Nitya Nair is a scholar working on Infectious Diseases, Biotechnology and Oncology. According to data from OpenAlex, Nitya Nair has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Biotechnology and 7 papers in Oncology. Recurrent topics in Nitya Nair's work include Cancer Research and Treatments (8 papers), Animal Virus Infections Studies (6 papers) and Virology and Viral Diseases (5 papers). Nitya Nair is often cited by papers focused on Cancer Research and Treatments (8 papers), Animal Virus Infections Studies (6 papers) and Virology and Viral Diseases (5 papers). Nitya Nair collaborates with scholars based in United States, Switzerland and Singapore. Nitya Nair's co-authors include Harry B. Greenberg, Evan W. Newell, Mark M. Davis, Natalia Sigal, Brian Kidd, Funda Meric‐Bernstam, Jason J. Luke, Nancy Lewis, Diane E. Griffin and Thomas W. Dubensky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Nitya Nair

26 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

2021 240 citations Funda Meric‐Bernstam, Randy F. Sweis et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Nitya Nair

Since Specialization

Citations

This map shows the geographic impact of Nitya Nair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nitya Nair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nitya Nair more than expected).

Fields of papers citing papers by Nitya Nair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nitya Nair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nitya Nair. The network helps show where Nitya Nair may publish in the future.

Co-authorship network of co-authors of Nitya Nair

This figure shows the co-authorship network connecting the top 25 collaborators of Nitya Nair. A scholar is included among the top collaborators of Nitya Nair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nitya Nair. Nitya Nair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subclinical infection and localization of foot-and-mouth disease viral RNA/antigens in apparently healthy Asiatic buffalo under natural condition 2025 ·Veterinary Microbiology ·Rajeev Ranjan, Jitendra K. Biswal, Nitya Nair, Karam Pal Singh, Biswajit Das, (unknown), Saravanan Subramaniam, Manoranjan Rout, Jonathan Arzt, Luis L. Rodrı́guez, Bramhadev Pattnaik	0
2	Serological Profiling of Foot and Mouth Disease Virus Nonstructural Protein Antibodies in Susceptible Wild or Captive Ruminants in India 2024 ·Indian Journal of Veterinary Pathology ·Michael P. Rout, M. Karikalan, (unknown), Nihar Ranjan Sahoo, Nitya Nair, Jajati K. Mohapatra, (unknown), Ashutosh Sharma, R. P. Singh	1
3	Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas breakdown → 2021 ·Clinical Cancer Research ·Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi, Wells A. Messersmith, Robert H.I. Andtbacka, Matthew Ingham, Nancy Lewis, Xinhui Chen, Marc R. Pelletier, Xueying Chen, Jincheng Wu, Thomas W. Dubensky, Sarah M. McWhirter, Thomas Müller, Nitya Nair, Jason J. Luke	240
4	Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer 2020 ·Cancer Immunology Research ·Nitya Nair, (unknown), Ed Lemmens, Serena Chang, Dung T. Le, Elizabeth M. Jaffee, Aimee Murphy, Chan C. Whiting, Thomas Müller, Dirk G. Brockstedt	17
5	Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma 2019 ·Clinical Cancer Research ·Raffit Hassan, Evan Alley, Hedy L. Kindler, Scott Antonia, Thierry Jahan, Somayeh Honarmand, Nitya Nair, Chan C. Whiting, Amanda Enstrom, Ed Lemmens, Takahiro Tsujikawa, Sushil Kumar, Gina Choe, Anish Thomas, (unknown), Aimee Murphy, Elizabeth M. Jaffee, Lisa M. Coussens, Dirk G. Brockstedt	88
6	Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas. 2019 ·Journal of Clinical Oncology ·Funda Meric‐Bernstam, Shahneen Sandhu, Omid Hamid, Anna Spreafico, Stefan Kasper, Reinhard Dummer, Toshio Shimizu, Neeltje Steeghs, Nancy Lewis, (unknown), (unknown), Andrew Bean, Robert J. Brown, (unknown), Nitya Nair, Jason J. Luke	140
7	Abstract CT107: Phase I/II safety and pharmacokinetics of BION-1301 targeting APRIL, a proliferation-inducing ligand, in adults with relapsed or refractory multiple myeloma 2019 ·Cancer Research ·Parameswaran Hari, Anastasios Raptis, James R. Berenson, Alexander I. Spira, Ajay K. Nooka, Maria Chaudhry, Nitya Nair, Hamid Namini, Jackie Walling, (unknown), William Bensinger	1
8	Results from a phase 2b, randomized, multicenter study of GVAX pancreas and CRS-207 compared to chemotherapy in adults with previously-treated metastatic pancreatic adenocarcinoma (ECLIPSE Study). 2017 ·Journal of Clinical Oncology ·Dung T. Le, Andrew H. Ko, Zev A. Wainberg, Vincent J. Picozzi, Hedy L. Kindler, Andrea Wang‐Gillam, Paul E. Oberstein, Michael A. Morse, Herbert J. Zeh, Colin D. Weekes, Tony R. Reid, Aimee Murphy, (unknown), Chan C. Whiting, Nitya Nair, Amanda Enstrom, Sandy Ferber, Thomas W. Dubensky, Dirk G. Brockstedt, Elizabeth M. Jaffee	39
9	VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans 2017 ·Science Translational Medicine ·Nitya Nair, Ningguo Feng, Lisa K. Blum, Mrinmoy Sanyal, Siyuan Ding, Baoming Jiang, Adrish Sen, John M. Morton, Xiao-Song He, William H. Robinson, Harry B. Greenberg	84
10	Pathological and Immunopathological Studies on Naturally Infected Cases of Porcine Circovirus-2 in Kerala 2017 ·International Journal of Livestock Research ·(unknown), (unknown), (unknown), (unknown), Nitya Nair	5
11	Clinical and immune characteristics of rapid dropout and long-term survival in a phase II safety and efficacy study of combination CRS-207/GVAX immunotherapy in pancreatic cancer. 2016 ·Journal of Clinical Oncology ·Dung T. Le, Chan C. Whiting, Eric R. Lutz, Nitya Nair, Amanda Engstrom, Ed Lemmens, (unknown), Aimee Murphy, Dirk G. Brockstedt, Elizabeth M. Jaffee	3
12	CRS-207 immunotherapy expressing mesothelin, combined with chemotherapy as treatment for malignant pleural mesothelioma (MPM). 2016 ·Journal of Clinical Oncology ·Raffit Hassan, Evan Alley, Hedy L. Kindler, Scott Antonia, Thierry Jahan, Somayeh Honarmand, (unknown), Chan C. Whiting, Nitya Nair, Amanda Enstrom, Ed Lemmens, Takahiro Tsujikawa, Sushil Kumar, Lisa M. Coussens, Aimee Murphy, Anish Thomas, Dirk G. Brockstedt	2
13	Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy 2015 ·Arthritis Research & Therapy ·Nitya Nair, Henrik E. Mei, Shih‐Yu Chen, Matthew B. Hale, Garry P. Nolan, Holden T. Maecker, Mark C. Genovese, C. Garrison Fathman, Chan C. Whiting	44
14	Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival. 2015 ·Journal of Clinical Oncology ·Chan C. Whiting, Eric R. Lutz, Nitya Nair, Serena Chang, Ed Lemmens, (unknown), Sara Solt, Sandy Ferber, Holden T. Maecker, Aimee Murphy, Dirk G. Brockstedt, Elizabeth M. Jaffee, Dung T. Le	9
15	High-dimensional immune profiling of total and rotavirus VP6-specific intestinal and circulating B cells by mass cytometry 2015 ·Mucosal Immunology ·Nitya Nair, Evan W. Newell, Christopher Vollmers, Stephen R. Quake, John M. Morton, Mark M. Davis, Xiaosong He, Harry B. Greenberg	35
16	Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution 2012 ·Proceedings of the National Academy of Sciences ·Adrish Sen, Michael E. Rothenberg, Gourab Mukherjee, Ningguo Feng, Tomer Kalisky, Nitya Nair, Iain M. Johnstone, Michael F. Clarke, Harry B. Greenberg	65
17	HIV‐1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus–Specific Immunoglobulin G after Vaccination and Infection 2009 ·The Journal of Infectious Diseases ·Nitya Nair, William J. Moss, Susana Scott, (unknown), Zaza M. Ndhlovu, (unknown), Judith J. Ryon, Mwaka Monze, Thomas C. Quinn, Simon Cousens, Felicity T. Cutts, (unknown)	52
18	Use of Vaxfectin Adjuvant with DNA Vaccine Encoding the Measles Virus Hemagglutinin and Fusion Proteins Protects Juvenile and Infant Rhesus Macaques against Measles Virus 2008 ·Clinical and Vaccine Immunology ·Chien-Hsiung Pan, Gretchen S. Jimenez, Nitya Nair, Qun Wei, Robert J. Adams, Fernando P. Polack, Alain Rolland, Adrián Vilalta, Diane E. Griffin	34
19	Age‐Dependent Differences in IgG Isotype and Avidity Induced by Measles Vaccine Received during the First Year of Life 2007 ·The Journal of Infectious Diseases ·Nitya Nair, Hayley A. Gans, (unknown), (unknown), Ann M. Arvin, Diane E. Griffin	54
20	Reversal reaction in multibacillary leprosy patients following MDT with and without immunotherapy with a candidate for an antileprosy vaccine,Mycobacterium w 1993 ·Leprosy Review ·H K Kar, Alok Sharma, R.S. Misra, (unknown), Sidra Zaheer, Rick Mukherjee, Aprateem Mukherjee, Shreemanta K. Parida, Rajat Walia, Nitya Nair, G.P. Talwar	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact